These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 3731424)

  • 1. Polymorphous ventricular tachycardia: clinical characterization, therapy, and the QT interval.
    Nguyen PT; Scheinman MM; Seger J
    Circulation; 1986 Aug; 74(2):340-9. PubMed ID: 3731424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymorphous ventricular tachycardia associated with acute myocardial infarction.
    Wolfe CL; Nibley C; Bhandari A; Chatterjee K; Scheinman M
    Circulation; 1991 Oct; 84(4):1543-51. PubMed ID: 1914096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug-induced torsade de pointes.
    Raehl CL; Patel AK; LeRoy M
    Clin Pharm; 1985; 4(6):675-90. PubMed ID: 2416504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amiodarone-induced polymorphous ventricular tachycardia.
    Sclarovsky S; Lewin RF; Kracoff O; Strasberg B; Arditti A; Agmon J
    Am Heart J; 1983 Jan; 105(1):6-12. PubMed ID: 6849241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymorphous ventricular tachycardia associated with a marked prolongation of the Q-T interval induced by amiodarone.
    Bhandari AK; Quock C; Sung RJ
    Pacing Clin Electrophysiol; 1984 May; 7(3 Pt 1):341-5. PubMed ID: 6204284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymorphous ventricular tachycardia: clinical features and treatment.
    Sclarovksy S; Strasberg B; Lewin RF; Agmon J
    Am J Cardiol; 1979 Aug; 44(2):339-44. PubMed ID: 463773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymorphous ventricular tachycardia associated with normal and long Q-T intervals.
    Soffer J; Dreifus LS; Michelson EL
    Am J Cardiol; 1982 Jun; 49(8):2021-9. PubMed ID: 7081082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overdrive pacing in quinidine syncope and other long QT-interval syndromes.
    DiSegni E; Klein HO; David D; Libhaber C; Kaplinsky E
    Arch Intern Med; 1980 Aug; 140(8):1036-40. PubMed ID: 7396607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced efficacy of oral sotalol for sustained ventricular tachycardia refractory to type I antiarrhythmic drugs.
    Kienzle MG; Martins JB; Wendt DJ; Constantin L; Hopson R; McCue ML
    Am J Cardiol; 1988 May; 61(13):1012-7. PubMed ID: 3129926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amiodarone versus amiodarone and a type IA agent for treatment of patients with rapid ventricular tachycardia.
    Marchlinski FE; Buxton AE; Miller JM; Vassallo JA; Flores BT; Josephson ME
    Circulation; 1986 Nov; 74(5):1037-43. PubMed ID: 3769163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of atrial pacing, isoprenaline and lignocaine on experimental polymorphous ventricular tachycardia.
    Inoue H; Matsuo H; Mashima S; Murao S
    Cardiovasc Res; 1984 Sep; 18(9):538-47. PubMed ID: 6467271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential effects of isoproterenol on sustained ventricular tachycardia before and during procainamide and quinidine antiarrhythmic drug therapy.
    Markel ML; Miles WM; Luck JC; Klein LS; Prystowsky EN
    Circulation; 1993 Mar; 87(3):783-92. PubMed ID: 8443899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reversal of antiarrhythmic drug effects by epinephrine: quinidine versus amiodarone.
    Calkins H; Sousa J; el-Atassi R; Schmaltz S; Kadish A; Morady F
    J Am Coll Cardiol; 1992 Feb; 19(2):347-52. PubMed ID: 1732363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Precordial QT interval dispersion as a marker of torsade de pointes. Disparate effects of class Ia antiarrhythmic drugs and amiodarone.
    Hii JT; Wyse DG; Gillis AM; Duff HJ; Solylo MA; Mitchell LB
    Circulation; 1992 Nov; 86(5):1376-82. PubMed ID: 1423949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Harmful interactions of amiodarone and class I anti-arrhythmia agents].
    Tartini R; Kappenberger L; Steinbrunn W
    Schweiz Med Wochenschr; 1982 Nov; 112(45):1585-7. PubMed ID: 7156952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Electrode-catheter arrhythmia induction in the selection and assessment of antiarrhythmic drug therapy for recurrent ventricular tachycardia.
    Mason JW; Winkle RA
    Circulation; 1978 Dec; 58(6):971-85. PubMed ID: 709781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The classical "R-on-T" phenomenon.
    Oksuz F; Sensoy B; Sahan E; Sen F; Baser K; Cetin H; Unal S; Ozeke O; Topaloglu S; Aras D
    Indian Heart J; 2015; 67(4):392-4. PubMed ID: 26304578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Value of a serial electropharmacologic study in survivors of a cardiac arrest secondary to ventricular tachycardia or ventricular fibrillation].
    Raviele A; Di Pede F; Delise P; Piccolo E
    G Ital Cardiol; 1984 Sep; 14(9):644-54. PubMed ID: 6510619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective evaluation of a discriminant function for prediction of recurrent symptomatic ventricular tachycardia or ventricular fibrillation in coronary artery disease patients receiving amiodarone and having inducible ventricular tachycardia at electrophysiologic study.
    Klein LS; Fineberg N; Heger JJ; Miles WM; Kammerling JM; Chang MS; Zipes DP; Prystowsky EN
    Am J Cardiol; 1988 May; 61(13):1024-30. PubMed ID: 3364357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Electrophysiologic assessment of antiarrhythmic drug efficacy for ventricular tachyarrhythmias associated with dilated cardiomyopathy.
    Rae AP; Spielman SR; Kutalek SP; Kay HR; Horowitz LN
    Am J Cardiol; 1987 Feb; 59(4):291-5. PubMed ID: 3544793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.